Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MORPHOSYS : Goldman Sachs sticks Neutral

share with twitter share with LinkedIn share with facebook
09/25/2020 | 09:45am EDT

Initially Neutral on the company, Goldman Sachs's analyst Graig Suvannavej maintained his recommendation. The target price is unchanged at EUR 110.

© MarketScreener with dpa-AFX Analyser 2020

Stocks mentioned in the article
ChangeLast1st jan.
MORPHOSYS AG 0.76% 87.56 Delayed Quote.-30.95%
THE GOLDMAN SACHS GROUP, INC. -0.47% 189.04 Delayed Quote.-17.78%
share with twitter share with LinkedIn share with facebook
All news about MORPHOSYS AG
10/30MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
10/28MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
10/28MORPHOSYS : Ad hoc, MorphoSys AG raises its Financial Guidance for the Full Year..
AQ
10/28MORPHOSYS : Goldman Sachs remains Neutral
MD
10/27AD HOC : MorphoSys AG Raises its Financial Guidance for the Full Year 2020
PU
10/27AD HOC : MorphoSys AG Raises its Financial Guidance for the Full Year 2020
EQ
10/20MORPHOSYS : Licensee Janssen Receives CHMP Positive Opinion for Tremfya for Trea..
AQ
10/19MORPHOSYS' : Licensee Janssen Receives CHMP Positive Opinion for Tremfya(R) (gus..
EQ
10/16MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
EQ
10/14MORPHOSYS AG : Successfully Places EUR 325 Million Convertible Bonds
AQ
More news
Financials
Sales 2020 324 M 377 M 377 M
Net income 2020 21,7 M 25,3 M 25,3 M
Net cash 2020 760 M 885 M 885 M
P/E ratio 2020 90,1x
Yield 2020 -
Capitalization 2 865 M 3 338 M 3 336 M
EV / Sales 2020 6,50x
EV / Sales 2021 8,40x
Nbr of Employees 572
Free-Float 95,1%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Average target price 127,44 €
Last Close Price 87,56 €
Spread / Highest target 82,7%
Spread / Average Target 45,5%
Spread / Lowest Target -58,8%
EPS Revisions
Managers
NameTitle
Jean-Paul Kress CEO & Member-Supervisory Board
Marc Cluzel Chairman-Supervisory Board
Roland Wandeler Chief Operating Officer
Jens Holstein Chief Financial Officer
Malte Peters Chief Research & Development Officer
Sector and Competitors
1st jan.Capitalization (M$)
MORPHOSYS AG-30.95%3 315
LONZA GROUP AG56.63%44 852
SEAGEN INC.45.98%33 467
CELLTRION, INC.33.15%29 849
IQVIA HOLDINGS INC.-0.34%29 650
MODERNA, INC.244.94%28 126